DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Trodusquemine is an investigational drug.
There have been 4 clinical trials for Trodusquemine. The most recent clinical trial was a Phase 1 trial, which was initiated on May 1st 2007.
The most common disease conditions in clinical trials are Diabetes Mellitus, Breast Neoplasms, and Overweight. The leading clinical trial sponsors are Genaera Corporation, Northwell Health, and DepYmed Inc.
Recent Clinical Trials for Trodusquemine
|Safety and Tolerability of MSI-1436C in Metastatic Breast Cancer||DepYmed Inc.||Phase 1|
|Safety and Tolerability of MSI-1436C in Metastatic Breast Cancer||Northwell Health||Phase 1|
|An Ascending Multi-Dose, Tolerance and Pharmacokinetic Study in Obese or Overweight Type 2 Diabetic Volunteers||Genaera Corporation||Phase 1|